The University of Southampton
University of Southampton Institutional Repository

Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma

Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma
Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma
Background: APC 366, a selective inhibitor of mast cell tryptase, has been shown to inhibit antigen-induced early asthmatic response (EAR), late asthmatic response (LAR), and bronchial hyperresponsiveness (BHR) in a sheep model of allergic asthma.
Objective: The purpose of this study was to investigate the effects of APC 366 on antigen-induced EAR, LAR, and BHR in mild atopic asthmatics not on any anti-inflammatory therapy.
Methods: Sixteen mild atopic asthmatics, each with a demonstrable antigen-induced EAR, LAR, and BHR to histamine, were recruited into this randomized, double-blinded, crossover study. APC 366 (5 mg)/placebo was administered by aerosol inhalation 3 times per day on treatment days 1 through 4. Allergen challenge was carried out on day 4. Histamine challenge was performed the following morning, 1 hour after final dosing.
Results: Subjects were shown to have a significantly smaller overall mean area under the curve for the LAR (P = .012) and mean maximum fall in FEV? for the LAR (P = .007) after pretreatment with APC 366 in comparison with placebo. No significant effects on BHR were demonstrable. Although the EAR was reduced by 18% after treatment with APC 366 in comparison with placebo, this was not statistically significant.
Conclusion: Short-term repeated administration of APC 366 significantly reduced the magnitude of antigen-induced LAR in atopic asthmatics, which supports the role of mast cell tryptase in the pathophysiology of the LAR.
APC 366, late asthmatic response, tryptase, asthma, mast cell, airway inflammation, bronchial hyperresponsiveness, early asthmatic response
0091-6749
1039-1045
Krishna, Mamidipudi Thirumala
71f53f82-8cff-417c-ac0c-aa8166b455d9
Chauhan, Anoop
1b479cfe-69ee-4a0e-95d1-b05060d39374
Little, Louise
41f55532-898e-41a6-97c6-2802a379d684
Sampson, Karen
e43ad5b6-8c55-4926-affb-5084affffec3
Hawksworth, Richard
ae3018bf-ce8b-4425-b060-d04457a84ce1
Mant, Tim
f712a94b-b891-4b11-b30c-20b3bc17c0be
Djukanovic, Ratko
d9a45ee7-6a80-4d84-a0ed-10962660a98d
Lee, Tak
1527b025-e980-487a-910b-616c284f5c7f
Holgate, Stephen
2e7c17a9-6796-436e-8772-1fe6d2ac5edc
Krishna, Mamidipudi Thirumala
71f53f82-8cff-417c-ac0c-aa8166b455d9
Chauhan, Anoop
1b479cfe-69ee-4a0e-95d1-b05060d39374
Little, Louise
41f55532-898e-41a6-97c6-2802a379d684
Sampson, Karen
e43ad5b6-8c55-4926-affb-5084affffec3
Hawksworth, Richard
ae3018bf-ce8b-4425-b060-d04457a84ce1
Mant, Tim
f712a94b-b891-4b11-b30c-20b3bc17c0be
Djukanovic, Ratko
d9a45ee7-6a80-4d84-a0ed-10962660a98d
Lee, Tak
1527b025-e980-487a-910b-616c284f5c7f
Holgate, Stephen
2e7c17a9-6796-436e-8772-1fe6d2ac5edc

Krishna, Mamidipudi Thirumala, Chauhan, Anoop, Little, Louise, Sampson, Karen, Hawksworth, Richard, Mant, Tim, Djukanovic, Ratko, Lee, Tak and Holgate, Stephen (2001) Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma. Journal of Allergy and Clinical Immunology, 107 (6), 1039-1045. (doi:10.1067/mai.2001.115631).

Record type: Article

Abstract

Background: APC 366, a selective inhibitor of mast cell tryptase, has been shown to inhibit antigen-induced early asthmatic response (EAR), late asthmatic response (LAR), and bronchial hyperresponsiveness (BHR) in a sheep model of allergic asthma.
Objective: The purpose of this study was to investigate the effects of APC 366 on antigen-induced EAR, LAR, and BHR in mild atopic asthmatics not on any anti-inflammatory therapy.
Methods: Sixteen mild atopic asthmatics, each with a demonstrable antigen-induced EAR, LAR, and BHR to histamine, were recruited into this randomized, double-blinded, crossover study. APC 366 (5 mg)/placebo was administered by aerosol inhalation 3 times per day on treatment days 1 through 4. Allergen challenge was carried out on day 4. Histamine challenge was performed the following morning, 1 hour after final dosing.
Results: Subjects were shown to have a significantly smaller overall mean area under the curve for the LAR (P = .012) and mean maximum fall in FEV? for the LAR (P = .007) after pretreatment with APC 366 in comparison with placebo. No significant effects on BHR were demonstrable. Although the EAR was reduced by 18% after treatment with APC 366 in comparison with placebo, this was not statistically significant.
Conclusion: Short-term repeated administration of APC 366 significantly reduced the magnitude of antigen-induced LAR in atopic asthmatics, which supports the role of mast cell tryptase in the pathophysiology of the LAR.

This record has no associated files available for download.

More information

Published date: 2001
Keywords: APC 366, late asthmatic response, tryptase, asthma, mast cell, airway inflammation, bronchial hyperresponsiveness, early asthmatic response
Organisations: Infection Inflammation & Immunity

Identifiers

Local EPrints ID: 27211
URI: http://eprints.soton.ac.uk/id/eprint/27211
ISSN: 0091-6749
PURE UUID: 98982e93-c241-45c5-94f5-b464fcbc2004
ORCID for Ratko Djukanovic: ORCID iD orcid.org/0000-0001-6039-5612

Catalogue record

Date deposited: 26 Apr 2006
Last modified: 16 Mar 2024 02:36

Export record

Altmetrics

Contributors

Author: Mamidipudi Thirumala Krishna
Author: Anoop Chauhan
Author: Louise Little
Author: Karen Sampson
Author: Richard Hawksworth
Author: Tim Mant
Author: Tak Lee
Author: Stephen Holgate

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×